What is the difference between FGF-1 and SYN-AKE?

FGF-1: Binds all four FGFR subtypes (broadest binding of FGF family). Activates MAPK and PI3K downstream pathways. Promotes fibroblast proliferation, angiogenesis, and hair follicle cycling into anagen phase. SYN-AKE: Reversibly antagonizes nicotinic acetylcholine receptors (nAChR) at neuromuscular junctions in facial skin, reducing involuntary muscle microcontractions. Effect is topical, localized, and fully reversible.

Is FGF-1 FDA approved?

FGF-1 is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is SYN-AKE FDA approved?

SYN-AKE is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is FGF-1 administered in research settings?

In research settings, FGF-1 is typically administered via the topical or subcutaneous routes. PeptideBase does not provide dosing or administration instructions.

How is SYN-AKE administered in research settings?

In research settings, SYN-AKE is typically administered via the topical route. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›FGF-1 vs SYN-AKE

Peptide Comparison

FGF-1 vs SYN-AKE

Both are Skin & Cosmetic peptides.

FGF-1

Fibroblast Growth Factor 1

Skin & JointNot EvaluatedResearch Only

No providers listed yet

Full FGF-1 profile →

SYN-AKE

Dipeptide Diaminobutyroyl Benzylamide Diacetate

Skin & JointNot EvaluatedResearch Only

1 providers listed

Full SYN-AKE profile →

Bottom line

FGF-1 has published research citations on file; SYN-AKE does not yet — the main evidence gap between them.

Quick Verdict

FGF-1

SYN-AKE

Which One Should You Choose?

Your goal	Better option
Has published research citations	FGF-1
More provider options (0 vs 1)	SYN-AKE

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

FGF-1

SYN-AKE

Mechanism Family

Skin & Cosmetic

Half-life

—

FDA Status

not evaluated

Admin Routes

topical, subcutaneous

topical

Availability

Research Only

Providers

None listed

1 listed

Research Evidence

FGF-1

RCT · 1 key study · dated evidence base — most recent 2008

SYN-AKE

No citations on file

Research Citations

FGF-1

RCT2008 · Molecular Therapy

Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critica…

SYN-AKE

No citations on file.

About FGF-1

Binds all four FGFR subtypes (broadest binding of FGF family). Activates MAPK and PI3K downstream pathways. Promotes fibroblast proliferation, angiogenesis, and hair follicle cycling into anagen phase.

Research Areas

wound healinghair growth supportskin repairangiogenesisfibroblast activation

About SYN-AKE

Reversibly antagonizes nicotinic acetylcholine receptors (nAChR) at neuromuscular junctions in facial skin, reducing involuntary muscle microcontractions. Effect is topical, localized, and fully reversible.

Research Areas

wrinkle reductionexpression line softeningmuscle relaxationanti-aging

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

FGF-1

Absolute Contraindications

Under clinical review

Being verified by our medical team before we display contraindications for this peptide.

SYN-AKE

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Find Providers

Where to source these peptides

Providers offering

FGF-1

Browse directory →

Providers offering

SYN-AKE

1 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Skin & Cosmetic Comparisons

Browse all peptides →

Educational research tools — not medical advice.